Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them. Send request.
SPD SCIENTIFIC PTE LTD
Class C IVD
Dako Denmark A/S
Gastroenterology & Urology
HER2 IQFISH pharmDx (Dako Omnis) is the hybridization probe for the automated direct fluorescence in situ hybridization (FISH) assay onboard Dako Omnis instruments and is, together with accessory reagent devices, designed to quantitatively determine HER2 gene amplification in formalin-fixed, paraffin-embedded (FFPE) breast cancer tissue specimens and FFPE specimens from patients with adenocarcinoma of the stomach including gastro-esophageal junction. HER2 IQFISH pharmDx is indicated in adjunction to HercepTest™ in the assessment of patients for whom Herceptin™ (trastuzumab) treatment is being considered. For breast cancer patients, results from HER2 IQFISH pharmDx (Dako Omnis) are intended for use as an adjunct to the clinicopathologic information currently used for estimating prognosis in stage II, node-positive breast cancer patients.
Models: Dako Omnis - GI100, HER2 IQFISH pharmDx (Dako Omnis) - GM333, ISH Ethanol solution,96% (Dako Omnis) - GM300, ISH Pepsin (Dako Omnis) - GM302, ISH Pre-treatment solution (20x) (Dako Omnis) - GM301, ISH Stringent wash buffer (20x) (Dako Omnis) - GM303, Fluorescence mounting medium (Dako Omnis) - GM304